基本信息
浏览量:0
职业迁徙
个人简介
A pioneer in the field of Cancer Immunotherapy, emergence of PD-L1/PD-1 inhibitors and next generation therapies. Focused on the future of medicine and what's possible at the intersection between engineering, science and medicine.
Experienced drug developer (from pre-clinical through Phase I-IV), entrepreneur, executive- strong communicator and strategic leader with expertise in Oncology, Immunology, Large Molecule Engineering, Virology, Filings, Biomarkers and Building/Leading Organizations.
Experienced drug developer (from pre-clinical through Phase I-IV), entrepreneur, executive- strong communicator and strategic leader with expertise in Oncology, Immunology, Large Molecule Engineering, Virology, Filings, Biomarkers and Building/Leading Organizations.
研究兴趣
论文共 120 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Katie M. Campbell, Zaid Bustami,Daniel G. Chen,Egmidio Medina,Cynthia R. Gonzalez, Nataly Naser Aldeen, Ignacio Baselga-Carretero,Agustin Vega-Crespo, Jessica Maxey, Jia M. Chen, Lawrence F. Kuklinski,Kari L. Kendra,
Cancer Researchno. 6_Supplement (2024): 6550-6550
Genetics in Medicine Open (2024): 101202
IMMUNITYno. 10 (2023): 2188-2205
Pei-Sung Hsu,Daniel Chen,Hui-Ping Chien,Chen Yeh, Peter Hong, Shu-Ti Lin, John-See Lee,Hung-Chih Lai
user-5d8054e8530c708f9920ccce(2020)
引用2浏览0引用
2
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn